SCHEMBL7366567

SCHEMBL7366567

COC(=O)C(N)C(N)C(=O)O

nearest known ligand 0.52

Predicted protein targets (top 11)

geneUniProtsupporting neighboursconfidence
SLC1A1 P43005 6/20 0.52
SLC1A3 P43003 6/20 0.52
SLC1A2 P43004 5/20 0.52
SLC7A5 Q01650 1/20 0.48
SMN1; SMN2 Q16637 2/20 0.40
KMT2A Q03164 1/20 0.37
ACHE P22303 1/20 0.35
CA14 Q9ULX7 1/20 0.34
USP2 O75604 1/20 0.33
SLCO1B1 Q9Y6L6 1/20 0.33
GFPT1 Q06210 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Valine SCHEMBL9296323 0.81 SLC7A5 (0.65) SLC1A1SLC1A3SLC1A2SLC7A5SMN1; SMN2
Valine SCHEMBL9296321 0.81 SLC7A5 (0.65) SLC1A1SLC1A3SLC1A2SLC7A5SMN1; SMN2
SCHEMBL18327305 0.80 SLC1A1 (0.43) SLC1A1SLC1A3SLC1A2SLC7A5SMN1; SMN2
SCHEMBL9782083 0.80 SLC1A1 (0.48) SLC1A1SLC1A3SLC1A2SLC7A5SMN1; SMN2
SCHEMBL15156436 0.80 SLC7A5 (0.50) SLC1A1SLC1A3SLC1A2SLC7A5SMN1; SMN2
SCHEMBL4114625 0.80 SLC1A1 (0.48) SLC1A1SLC1A3SLC1A2SLC7A5SMN1; SMN2
SCHEMBL5019033 0.80 SLC1A1 (0.48) SLC1A1SLC1A3SLC1A2SLC7A5SMN1; SMN2
SCHEMBL11004061 0.80 SLC1A1 (0.43) SLC1A1SLC1A3SLC1A2SLC7A5SMN1; SMN2
SCHEMBL9782088 0.80 SLC1A1 (0.43) SLC1A1SLC1A3SLC1A2SLC7A5SMN1; SMN2
Hydrochloric Acid SCHEMBL4082393 0.78 SLC1A1 (0.46) SLC1A1SLC1A3SLC1A2SLC7A5SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-1997048444-A1 IONTOPHORETIC DELIVERY OF CELL ADHESION INHIBITORS BECTON DICKINSON AND COMPANY (US) 1997-12-24 WO claimed
WO-1995014683-A1 NOVEL ISOXAZOLINE AND ISOXAZOLE FIBRINOGEN RECEPTOR ANTAGONISTS THE DU PONT MERCK PHARMACEUTICAL COMPANY (US) 1995-06-01 WO claimed
WO-2020006722-A1 CROSS-LINKED PYRROLOBENZODIAZEPINE DIMER (PBD) DERIVATIVE AND ITS CONJUGATES HANGZHOU DAC BIOTECH CO., LTD (CN) 2020-01-09 WO disclosed